US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Elutia

0.9049

+0.01491.67%

Post-market: 0.8960-0.0089-0.98%19:19 EDT

Volume:394.68K

Turnover:354.97K

Market Cap:38.36M

PE:-1.16

High:0.9846

Open:0.8913

Low:0.8816

Close:0.8900

52wk High:5.12

52wk Low:0.8500

Shares:42.40M

Float Shares:15.39M

Volume Ratio:0.95

T/O Rate:2.57%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.7818

EPS(LYR):-1.8558

ROE:--

ROA:-37.27%

PB:-0.92

PE(LYR):-0.49

Loading ...

Overview Company News Filings

The Market Doesn't Like What It Sees From Elutia Inc.'s (NASDAQ:ELUT) Revenues Yet As Shares Tumble 30%

Simply Wall St.

BRIEF-Elutia Appoints Accomplished MedTech Veteran Guido J. Neels To Board Of Directors

Press Release: Elutia Appoints Accomplished MedTech Veteran Guido J. Neels to Board of Directors

Elutia closes sale of BioEnvelope business to Boston Scientific for 88 million

SWK Holdings Corp. Announces Full Repayment of Elutia Loan Following $27.8 Million Payoff

Elutia Inc - Plans NXT-41X Market Launch in First Half 2027

THOMSON REUTERS

Press Release: Elutia Announces Closing of BioEnvelope Business Sale to Boston Scientific Corporation for $88 Million

Elutia Announces Newly Published Clinical Data Demonstrating that Biologic Envelopes Support CIED Stabilization and Ease of Reoperation

Elutia Is Maintained at Buy by Lake Street

Elutia Inc. Unveils Presentation Detailing Innovative Drug-Eluting Biomatrices and Market Strategy

Boston Scientific to Buy Elutia's Bioenvelope Business for $88M

BRIEF-Elutia Announces Sale of BioEnvelope Business to Boston Scientific Corporation for $88 Million

Elutia Selected to Exhibit EluPro™ Antibiotic Eluting BioEnvelope at Vizient Innovative Technology Exchange

Elutia to Participate in Upcoming Investor Conferences

BRIEF-Elutia Enters Fifth Amendment To Credit Agreement

Elutia Inc - on August 15 Enters Fifth Amendment to Credit Agreement - SEC Filing

THOMSON REUTERS

Elutia Inc - SWK Facility Provides $25 Mln Term Loan - SEC Filing

THOMSON REUTERS

Elutia Inc. Amends Credit Agreement, Capitalizes $60,000 in Fees into $25 Million Term Loan

Cantor Fitzgerald Adjusts Elutia Price Target to $5 From $7, Maintains Overweight Rating

MT Newswires Live

Elutia Inc reports results for the quarter ended June 30 - Earnings Summary

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ELUT/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ELUT","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ELUT\",,,,,undefined,":{"symbol":"ELUT","market":"US","secType":"STK","nameCN":"Elutia","latestPrice":0.9049,"timestamp":1760385600000,"preClose":0.89,"halted":0,"volume":394677,"hourTrading":{"tag":"盘后","latestPrice":0.896,"preClose":0.9049,"latestTime":"19:19 EDT","volume":1152,"amount":1031.7662,"timestamp":1760397558340},"delay":0,"floatShares":15385260,"shares":42395341,"eps":-0.781826,"marketStatus":"Not Yet Opened","change":0.0149,"latestTime":"10-13 16:00:00 EDT","open":0.8913,"high":0.9846,"low":0.8816,"amount":354965.05808532,"amplitude":0.11573,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.781826,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1760428800000},"marketStatusCode":0,"adr":0,"listingDate":1602129600000,"exchange":"NASDAQ","adjPreClose":0.89,"preHourTrading":{"tag":"盘前","latestPrice":0.89,"preClose":0.89,"latestTime":"08:39 EDT","volume":11348,"amount":10170.676207,"timestamp":1760359197940},"postHourTrading":{"tag":"盘后","latestPrice":0.896,"preClose":0.9049,"latestTime":"19:19 EDT","volume":1152,"amount":1031.7662,"timestamp":1760397558340},"volumeRatio":0.951159},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ELUT\",,,,,undefined,":{"symbol":"ELUT","floatShares":15385260,"roa":"-37.27%","roe":"--","lyrEps":-1.855759,"volumeRatio":0.951159,"shares":42395341,"dividePrice":0,"high":0.9846,"amplitude":0.11573,"preClose":0.89,"low":0.8816,"week52Low":0.85,"pbRate":"-0.92","psRate":"1.62","week52High":5.12,"institutionHeld":0,"latestPrice":0.9049,"eps":-0.781826,"divideRate":0,"volume":394677,"delay":0,"ttmEps":-0.781826,"open":0.8913,"prevYearClose":3.74,"prevWeekClose":0.89,"prevMonthClose":0.8902,"prevQuarterClose":0.8902,"fiveDayClose":0.8813,"twentyDayClose":1.22,"sixtyDayClose":2.115},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ELUT\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-08-14","symbol":"ELUT","fiscalQuarterEnding":"2025/06","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1755144000000,"reportTimeType":"post","actualEps":-0.26},{"market":"US","date":"2025-05-08","symbol":"ELUT","fiscalQuarterEnding":"2025/03","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1746676800000,"reportTimeType":"post","actualEps":-0.21},{"market":"US","date":"2025-03-06","symbol":"ELUT","fiscalQuarterEnding":"2024/12","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1741237200000,"reportTimeType":"post","actualEps":-0.26},{"market":"US","date":"2024-11-14","symbol":"ELUT","fiscalQuarterEnding":"2024/09","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1731560400000,"reportTimeType":"post","actualEps":-0.33},{"market":"US","date":"2024-08-07","symbol":"ELUT","fiscalQuarterEnding":"2024/06","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1723003200000,"reportTimeType":"post","actualEps":-1.14}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ELUT\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ELUT\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":2,"updateTime":1696132800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ELUT\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ELUT","date":"2025-10-10","current":-1.157419,"percent":0.718876,"low":-4.772906,"twenty":-2.391382,"median":-1.989268,"eighty":-1.669575,"high":-0.540943,"avg":-2.002437,"sd":0.634824,"marketCap":37413888},"quantilePoints":[{"date":"2023-09-15","current":-0.550518,"twenty":-0.608921,"median":-0.57924,"eighty":-0.548603,"marketCap":18687324},{"date":"2023-09-22","current":-0.732428,"twenty":-0.740087,"median":-0.598389,"eighty":-0.548603,"marketCap":24862265},{"date":"2023-09-29","current":-0.925604,"twenty":-0.854822,"median":-0.732428,"eighty":-0.573496,"marketCap":31419614},{"date":"2023-10-06","current":-0.877962,"twenty":-0.929687,"median":-0.810097,"eighty":-0.59073,"marketCap":29802428},{"date":"2023-10-13","current":-0.925604,"twenty":-0.925604,"median":-0.860947,"eighty":-0.599346,"marketCap":31419614},{"date":"2023-10-20","current":-0.89838,"twenty":-0.951466,"median":-0.884768,"eighty":-0.62041,"marketCap":30495508},{"date":"2023-10-27","current":-0.78268,"twenty":-0.946021,"median":-0.884768,"eighty":-0.631899,"marketCap":26568056},{"date":"2023-11-03","current":-0.911992,"twenty":-0.929687,"median":-0.884768,"eighty":-0.712322,"marketCap":30957561},{"date":"2023-11-10","current":-1.000469,"twenty":-0.959633,"median":-0.891574,"eighty":-0.763066,"marketCap":33960907},{"date":"2023-11-17","current":-1.104073,"twenty":-0.980051,"median":-0.89838,"eighty":-0.780289,"marketCap":37297800},{"date":"2023-11-24","current":-1.270365,"twenty":-0.999262,"median":-0.911992,"eighty":-0.786996,"marketCap":42915471},{"date":"2023-12-01","current":-1.256631,"twenty":-1.107415,"median":-0.925604,"eighty":-0.801891,"marketCap":42451520},{"date":"2023-12-08","current":-1.373368,"twenty":-1.121435,"median":-0.939215,"eighty":-0.813987,"marketCap":46395104},{"date":"2023-12-15","current":-1.359634,"twenty":-1.252511,"median":-0.959633,"eighty":-0.824876,"marketCap":45931152},{"date":"2023-12-22","current":-1.339033,"twenty":-1.319806,"median":-0.973245,"eighty":-0.842572,"marketCap":45235226},{"date":"2023-12-29","current":-1.45577,"twenty":-1.339033,"median":-0.980051,"eighty":-0.854822,"marketCap":49178810},{"date":"2024-01-05","current":-1.929581,"twenty":-1.359634,"median":-0.986857,"eighty":-0.867073,"marketCap":65185121},{"date":"2024-01-12","current":-2.217989,"twenty":-1.373368,"median":-1.000469,"eighty":-0.876601,"marketCap":74928092},{"date":"2024-01-19","current":-2.423994,"twenty":-1.431049,"median":-1.101384,"eighty":-0.882046,"marketCap":81887358},{"date":"2024-01-26","current":-2.746735,"twenty":-1.572506,"median":-1.114716,"eighty":-0.884768,"marketCap":92790208},{"date":"2024-02-02","current":-2.526996,"twenty":-1.981769,"median":-1.12197,"eighty":-0.888852,"marketCap":85366991},{"date":"2024-02-09","current":-2.544163,"twenty":-2.252323,"median":-1.229164,"eighty":-0.891574,"marketCap":85946930},{"date":"2024-02-16","current":-2.629999,"twenty":-2.386913,"median":-1.263498,"eighty":-0.895658,"marketCap":88846624},{"date":"2024-02-23","current":-2.307258,"twenty":-2.444594,"median":-1.290965,"eighty":-0.89838,"marketCap":77943774},{"date":"2024-03-01","current":-2.499529,"twenty":-2.444594,"median":-1.339033,"eighty":-0.901102,"marketCap":84439089},{"date":"2024-03-08","current":-2.465195,"twenty":-2.469315,"median":-1.352767,"eighty":-0.907908,"marketCap":83279211},{"date":"2024-03-15","current":-2.101428,"twenty":-2.462448,"median":-1.366501,"eighty":-0.914714,"marketCap":79131372},{"date":"2024-03-22","current":-2.062751,"twenty":-2.444594,"median":-1.373368,"eighty":-0.92152,"marketCap":77674966},{"date":"2024-03-28","current":-2.030521,"twenty":-2.423994,"median":-1.407702,"eighty":-0.925604,"marketCap":76461295},{"date":"2024-04-05","current":-1.991844,"twenty":-2.422621,"median":-1.469503,"eighty":-0.926965,"marketCap":75004889},{"date":"2024-04-12","current":-1.959549,"twenty":-2.40614,"median":-1.575939,"eighty":-0.933771,"marketCap":73788790},{"date":"2024-04-19","current":-1.96606,"twenty":-2.361505,"median":-1.8178,"eighty":-0.940576,"marketCap":74033952},{"date":"2024-04-26","current":-1.868793,"twenty":-2.353952,"median":-1.846646,"eighty":-0.948743,"marketCap":70371251},{"date":"2024-05-03","current":-1.810595,"twenty":-2.330605,"median":-1.843584,"eighty":-0.959633,"marketCap":68179759},{"date":"2024-05-10","current":-1.810595,"twenty":-2.314124,"median":-1.846646,"eighty":-0.960994,"marketCap":68179759},{"date":"2024-05-17","current":-1.644574,"twenty":-2.312751,"median":-1.842927,"eighty":-0.9678,"marketCap":78406723},{"date":"2024-05-24","current":-1.659896,"twenty":-2.304511,"median":-1.810595,"eighty":-0.974606,"marketCap":79137220},{"date":"2024-05-31","current":-1.644574,"twenty":-2.293524,"median":-1.794429,"eighty":-0.980051,"marketCap":78406723},{"date":"2024-06-07","current":-1.736507,"twenty":-2.272923,"median":-1.736507,"eighty":-0.980051,"marketCap":82789707},{"date":"2024-06-14","current":-1.976554,"twenty":-2.261937,"median":-1.746722,"eighty":-0.985496,"marketCap":94234167},{"date":"2024-06-21","current":-2.009118,"twenty":-2.238589,"median":-1.746722,"eighty":-0.993817,"marketCap":95786700},{"date":"2024-06-28","current":-2.447891,"twenty":-2.25919,"median":-1.772259,"eighty":-0.998457,"marketCap":116705635},{"date":"2024-07-05","current":-2.528717,"twenty":-2.308631,"median":-1.797662,"eighty":-1.000067,"marketCap":120559123},{"date":"2024-07-12","current":-2.644184,"twenty":-2.359446,"median":-1.814198,"eighty":-1.000469,"marketCap":126064106},{"date":"2024-07-15","current":-2.540264,"twenty":-2.362192,"median":-1.8178,"eighty":-1.000469,"marketCap":121109621},{"date":"2024-08-02","current":-1.974478,"twenty":-2.361505,"median":-1.830364,"eighty":-1.020114,"marketCap":94135205},{"date":"2024-08-09","current":-1.29534,"twenty":-2.353952,"median":-1.810595,"eighty":-1.09977,"marketCap":84501485},{"date":"2024-08-16","current":-1.754315,"twenty":-2.330605,"median":-1.781728,"eighty":-1.105744,"marketCap":114442745},{"date":"2024-08-23","current":-2.093692,"twenty":-2.314124,"median":-1.810595,"eighty":-1.112886,"marketCap":136581967},{"date":"2024-08-30","current":-2.140682,"twenty":-2.312751,"median":-1.830364,"eighty":-1.115007,"marketCap":139647398},{"date":"2024-09-06","current":-2.109355,"twenty":-2.307258,"median":-1.845034,"eighty":-1.116169,"marketCap":137603777},{"date":"2024-09-13","current":-2.271212,"twenty":-2.293524,"median":-1.853208,"eighty":-1.119295,"marketCap":148162483},{"date":"2024-09-20","current":-1.99971,"twenty":-2.272923,"median":-1.868793,"eighty":-1.124646,"marketCap":130451106},{"date":"2024-09-27","current":-2.04148,"twenty":-2.271212,"median":-1.875815,"eighty":-1.198295,"marketCap":133175933},{"date":"2024-10-04","current":-1.989268,"twenty":-2.26599,"median":-1.888192,"eighty":-1.198295,"marketCap":129769899},{"date":"2024-10-11","current":-1.957941,"twenty":-2.25919,"median":-1.894658,"eighty":-1.201697,"marketCap":127726278},{"date":"2024-10-18","current":-1.871792,"twenty":-2.245106,"median":-1.91272,"eighty":-1.229164,"marketCap":122106322},{"date":"2024-10-25","current":-1.68644,"twenty":-2.224855,"median":-1.894658,"eighty":-1.249764,"marketCap":110014901},{"date":"2024-10-31","current":-1.655113,"twenty":-2.224348,"median":-1.888192,"eighty":-1.255258,"marketCap":107971280},{"date":"2024-11-08","current":-1.978826,"twenty":-2.219235,"median":-1.891425,"eighty":-1.263969,"marketCap":129088692},{"date":"2024-11-15","current":-1.99971,"twenty":-2.191779,"median":-1.91095,"eighty":-1.269453,"marketCap":130451106},{"date":"2024-11-22","current":-2.764944,"twenty":-2.238694,"median":-1.926614,"eighty":-1.270365,"marketCap":149865500},{"date":"2024-11-29","current":-2.639886,"twenty":-2.266998,"median":-1.927383,"eighty":-1.284312,"marketCap":143087085},{"date":"2024-12-06","current":-2.748287,"twenty":-2.299018,"median":-1.929581,"eighty":-1.294648,"marketCap":148962642},{"date":"2024-12-13","current":-2.525108,"twenty":-2.344339,"median":-1.940802,"eighty":-1.305076,"marketCap":136865908},{"date":"2024-12-20","current":-2.250917,"twenty":-2.413049,"median":-1.95272,"eighty":-1.323927,"marketCap":122004205},{"date":"2024-12-27","current":-2.646262,"twenty":-2.438332,"median":-1.956124,"eighty":-1.334913,"marketCap":143432706},{"date":"2025-01-03","current":-2.168022,"twenty":-2.456241,"median":-1.957941,"eighty":-1.339033,"marketCap":117511133},{"date":"2025-01-10","current":-2.168022,"twenty":-2.447891,"median":-1.959614,"eighty":-1.339033,"marketCap":117511133},{"date":"2025-01-17","current":-2.046868,"twenty":-2.423994,"median":-1.970269,"eighty":-1.3459,"marketCap":110944334},{"date":"2025-01-24","current":-2.091504,"twenty":-2.423994,"median":-1.97769,"eighty":-1.356887,"marketCap":113363681},{"date":"2025-01-31","current":-1.976726,"twenty":-2.4185,"median":-1.976554,"eighty":-1.359634,"marketCap":107142503},{"date":"2025-02-07","current":-1.937476,"twenty":-2.411689,"median":-1.970269,"eighty":-1.365128,"marketCap":105015096},{"date":"2025-02-14","current":-2.114955,"twenty":-2.389925,"median":-1.974478,"eighty":-1.371995,"marketCap":114634800},{"date":"2025-02-21","current":-2.366383,"twenty":-2.395026,"median":-1.976726,"eighty":-1.373368,"marketCap":128262713},{"date":"2025-02-28","current":-2.329409,"twenty":-2.395026,"median":-1.980336,"eighty":-1.373368,"marketCap":126258608},{"date":"2025-03-07","current":-1.885712,"twenty":-2.395026,"median":-1.984047,"eighty":-1.389848,"marketCap":102209349},{"date":"2025-03-14","current":-2.414629,"twenty":-2.395026,"median":-1.984047,"eighty":-1.409075,"marketCap":130266818},{"date":"2025-03-21","current":-2.446524,"twenty":-2.415305,"median":-1.989268,"eighty":-1.43929,"marketCap":131987517},{"date":"2025-03-28","current":-2.008566,"twenty":-2.412303,"median":-1.989268,"eighty":-1.46401,"marketCap":108360122},{"date":"2025-04-04","current":-2.197341,"twenty":-2.410499,"median":-1.989268,"eighty":-1.510704,"marketCap":118544344},{"date":"2025-04-11","current":-1.691424,"twenty":-2.404863,"median":-1.989268,"eighty":-1.550532,"marketCap":91250629},{"date":"2025-04-17","current":-1.58571,"twenty":-2.39466,"median":-1.984722,"eighty":-1.546412,"marketCap":85547464},{"date":"2025-04-25","current":-1.638567,"twenty":-2.383364,"median":-1.984047,"eighty":-1.56571,"marketCap":88399046},{"date":"2025-05-02","current":-1.668771,"twenty":-2.381173,"median":-1.980336,"eighty":-1.579955,"marketCap":90028522},{"date":"2025-05-09","current":-1.507402,"twenty":-2.381173,"median":-1.976726,"eighty":-1.525919,"marketCap":81322850},{"date":"2025-05-16","current":-1.782652,"twenty":-2.375257,"median":-1.975516,"eighty":-1.539065,"marketCap":71106411},{"date":"2025-05-23","current":-1.741671,"twenty":-2.364707,"median":-1.96606,"eighty":-1.547751,"marketCap":69471781},{"date":"2025-05-30","current":-1.690446,"twenty":-2.361505,"median":-1.959614,"eighty":-1.562241,"marketCap":67428494},{"date":"2025-06-06","current":-1.876016,"twenty":-2.353952,"median":-1.959582,"eighty":-1.578036,"marketCap":74830508},{"date":"2025-06-13","current":-1.94817,"twenty":-2.333662,"median":-1.959549,"eighty":-1.587189,"marketCap":77708604},{"date":"2025-06-20","current":-1.845092,"twenty":-2.329409,"median":-1.957941,"eighty":-1.593106,"marketCap":73597038},{"date":"2025-06-27","current":-1.906939,"twenty":-2.322014,"median":-1.954422,"eighty":-1.615914,"marketCap":76063978},{"date":"2025-07-03","current":-2.154326,"twenty":-2.315702,"median":-1.957941,"eighty":-1.622499,"marketCap":85931737},{"date":"2025-07-11","current":-2.525406,"twenty":-2.330472,"median":-1.959549,"eighty":-1.625643,"marketCap":100733376},{"date":"2025-07-18","current":-2.092479,"twenty":-2.330472,"median":-1.96466,"eighty":-1.636057,"marketCap":83464797},{"date":"2025-07-25","current":-1.958478,"twenty":-2.323493,"median":-1.967056,"eighty":-1.638567,"marketCap":78119761},{"date":"2025-08-01","current":-2.092479,"twenty":-2.315702,"median":-1.975516,"eighty":-1.639273,"marketCap":83464797},{"date":"2025-08-08","current":-2.04094,"twenty":-2.314124,"median":-1.978826,"eighty":-1.643549,"marketCap":81409014},{"date":"2025-08-15","current":-2.216172,"twenty":-2.311316,"median":-1.979093,"eighty":-1.644574,"marketCap":88398677},{"date":"2025-08-22","current":-4.375164,"twenty":-2.330472,"median":-1.984047,"eighty":-1.645809,"marketCap":93269750},{"date":"2025-08-29","current":-4.633697,"twenty":-2.36303,"median":-1.984047,"eighty":-1.653314,"marketCap":98781144},{"date":"2025-09-05","current":-3.997309,"twenty":-2.381173,"median":-1.987333,"eighty":-1.657983,"marketCap":85214635},{"date":"2025-09-12","current":-2.605211,"twenty":-2.410499,"median":-1.989268,"eighty":-1.659896,"marketCap":55537896},{"date":"2025-09-19","current":-2.147808,"twenty":-2.412303,"median":-1.989268,"eighty":-1.659896,"marketCap":45786968},{"date":"2025-09-26","current":-2.048372,"twenty":-2.410499,"median":-1.991844,"eighty":-1.663291,"marketCap":43667201},{"date":"2025-10-03","current":-1.78447,"twenty":-2.404863,"median":-1.989268,"eighty":-1.667485,"marketCap":38041339},{"date":"2025-10-10","current":-1.755037,"twenty":-2.391382,"median":-1.989268,"eighty":-1.669575,"marketCap":37413888}],"updateTime":1760423669051},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ELUT\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2575559405","title":"The Market Doesn't Like What It Sees From Elutia Inc.'s (NASDAQ:ELUT) Revenues Yet As Shares Tumble 30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2575559405","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575559405?lang=en_us&edition=fundamental","pubTime":"2025-10-13 18:23","pubTimestamp":1760350992,"startTime":"0","endTime":"0","summary":"To the annoyance of some shareholders, Elutia Inc. ( NASDAQ:ELUT ) shares are down a considerable 30% in the last...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-elut/elutia/news/the-market-doesnt-like-what-it-sees-from-elutia-incs-nasdaqe","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-elut/elutia/news/the-market-doesnt-like-what-it-sees-from-elutia-incs-nasdaqe","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":[".IXIC","ELUT"],"gpt_icon":0},{"id":"2574417592","title":"BRIEF-Elutia Appoints Accomplished MedTech Veteran Guido J. Neels To Board Of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2574417592","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574417592?lang=en_us&edition=fundamental","pubTime":"2025-10-10 20:10","pubTimestamp":1760098234,"startTime":"0","endTime":"0","summary":"BRIEF-Elutia Appoints Accomplished MedTech Veteran Guido J. Neels To Board Of DirectorsOct 10 (Reuters) - Elutia Inc ELUT.O:ELUTIA APPOINTS ACCOMPLISHED MEDTECH VETERAN GUIDO J. NEELS TO BOARD OF DIRE","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251010:nTUA16CFN5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ELUT"],"gpt_icon":0},{"id":"2574175556","title":"Press Release: Elutia Appoints Accomplished MedTech Veteran Guido J. Neels to Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2574175556","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574175556?lang=en_us&edition=fundamental","pubTime":"2025-10-10 20:00","pubTimestamp":1760097600,"startTime":"0","endTime":"0","summary":"Industry leader brings 40 years of executive and board experience across the global medical technology sector. GAITHERSBURG, Md., Oct. 10, 2025  -- Elutia Inc.  , a pioneer in drug-eluting biomatrix technologies, announced the appointment of Guido J. Neels to the Company's Board of Directors. Mr. Neels will also serve as a member of the audit committee of the Board. In conjunction with Mr. Neels' appointment, W. Matthew Zuga and Maybelle Jordan have both stepped down as members of Elutia's Board.\"Randy and I are excited to welcome Guido to our Board of Directors and the Elutia CRU,\" said Kevin Rakin, Executive Chairman of Elutia. \"Guido's extensive medical technology leadership experience encompasses a broad range of managerial and strategic roles. His insights will be invaluable as we embark on building significant shareholder value, leveraging our demonstrated drug-eluting biomatrix technology, following our recent EluPro divestiture. We also thank Matt Zuga and Maybelle Jordan for t","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4567","IE00BFXG0V08.USD","BK4585","BK4588","BK4139","BK4022","BK4232","ELUT","IE00BYQQ9H92.USD","R","IE00BN0W2V16.EUR","EW","BK4082","IE00BN0W2W23.USD","BK4504","IE00BN0W2T93.GBP"],"gpt_icon":0},{"id":"2573299658","title":"Elutia closes sale of BioEnvelope business to Boston Scientific for 88 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2573299658","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573299658?lang=en_us&edition=fundamental","pubTime":"2025-10-08 05:01","pubTimestamp":1759870883,"startTime":"0","endTime":"0","summary":"Elutia Inc. has completed the sale of its BioEnvelope business, including the EluPro and CanGaroo bioenvelopes, to Boston Scientific Corporation for $88 million in cash. With the transaction finalized, Elutia will focus on advancing its NXT-41x drug-eluting biomatrix platform, aimed at reducing reconstruction infections following mastectomy. The company plans to bring NXT-41x to market in the first half of 2027, targeting the $1.5 billion U.S. breast reconstruction biologics market.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Elutia Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251007:nNDL7hgb1v:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","ELUT","LU0225283273.USD","LU0114720955.EUR","LU1718418525.SGD","LU2244417387.USD","LU0823417737.USD","LU2362541513.USD","LU2506952097.USD","BK4139","BK4581","LU1989772840.SGD","SG9999001176.USD","IE0009355771.USD","IE00BJT1NW94.SGD","SGXZ57979304.SGD","LU2242649171.HKD","LU0251132253.USD","LU0238689110.USD","LU2324357040.USD","LU2491050154.USD","LU2362540622.SGD","LU1989764664.SGD","IE00BJJMRZ35.SGD","LU0950375773.USD","SG9999013999.USD","LU0353189680.USD","LU1791710582.SGD","LU1791710400.SGD","BK4588","LU2265009873.SGD","LU0882574055.USD","LU1720051017.SGD","BSX","IE0002141913.USD","LU1153585028.USD","LU2506951875.HKD","IE00B4R5TH58.HKD","LU2362541273.HKD","LU0267386448.USD","LU1057294990.SGD","LU1989771016.USD","LU1023059063.AUD","BK4082","LU0345769631.USD","LU0011850046.USD","LU2087625088.SGD","BK4504","IE00B2B36J28.USD","LU1548497426.USD"],"gpt_icon":0},{"id":"2572550840","title":"SWK Holdings Corp. Announces Full Repayment of Elutia Loan Following $27.8 Million Payoff","url":"https://stock-news.laohu8.com/highlight/detail?id=2572550840","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572550840?lang=en_us&edition=fundamental","pubTime":"2025-10-02 04:39","pubTimestamp":1759351155,"startTime":"0","endTime":"0","summary":"SWK Holdings Corp. , a specialty finance company focused on the life sciences sector, announced on October 1, 2025, that Elutia, Inc. has fully repaid its loan with a $27.8 million payoff. This payment, which includes outstanding principal, exit fees, and accrued interest, follows Elutia's $88 million sale of its BioEnvelope business to Boston Scientific Corporation. The repayment exceeds SWK Holdings' net GAAP carrying value of the loan, and the company expects to recognize approximately $2.8 million in incremental income as a result of the transaction.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SWK Holdings Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, an","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251001:nNDL1DsKtX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","LU0114720955.EUR","LU1989772840.SGD","LU0823416689.USD","LU2357305700.SGD","LU2362541273.HKD","LU0353189680.USD","LU2362541513.USD","LU0823417653.USD","SWKH","LU2265009873.SGD","LU1548497426.USD","LU1057294990.SGD","LU1061106388.HKD","SGXZ57979304.SGD","LU0882574055.USD","BK4581","ELUT","LU1720051108.HKD","SG9999001176.USD","BK4588","IE00BJT1NW94.SGD","LU1718418525.SGD","LU2087625088.SGD","LU0048584097.USD","LU2112291526.USD","LU0238689110.USD","LU2506952097.USD","LU0077335932.USD","LU2491049909.HKD","LU2491050071.SGD","LU0345769631.USD","LU0011850046.USD","LU1989772923.USD","LU0266013472.USD","LU1989764664.SGD","LU1023059063.AUD","LU1366192091.USD","LU1983299246.USD","LU2506952170.USD","LU0950375773.USD","IE0002141913.USD","LU1989764748.USD","BK4504","LU2491050154.USD","BSX","LU1291159041.SGD","LU0187121727.USD","LU0345769128.USD","LU1153585028.USD"],"gpt_icon":0},{"id":"2572315965","title":"Elutia Inc - Plans NXT-41X Market Launch in First Half 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2572315965","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572315965?lang=en_us&edition=fundamental","pubTime":"2025-10-01 20:41","pubTimestamp":1759322494,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251001:nTUABGXC4L:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1366192091.USD","LU0077335932.USD","LU2242649171.HKD","BK4585","LU1720051017.SGD","LU1804176565.USD","LU0048584097.USD","LU2324357040.USD","LU2506952097.USD","LU0345769128.USD","LU2491050071.SGD","IE0002141913.USD","LU0345769631.USD","LU0353189680.USD","LU1720051108.HKD","LU2491050154.USD","LU0225283273.USD","LU1153585028.USD","LU0823416689.USD","LU2112291526.USD","LU2244417387.USD","BSX","LU0122379950.USD","LU0114720955.EUR","LU2362541513.USD","BK4082","SG9999001176.SGD","LU2265009873.SGD","BK4504","LU0266013472.USD","ELUT","LU1291159041.SGD","IE0009355771.USD","LU2362540622.SGD","LU0528227936.USD","IE00BJT1NW94.SGD","LU0251132253.USD","LU1983299246.USD","LU2087625088.SGD","LU2491049909.HKD","SG9999001176.USD","LU2506951875.HKD","IE00B2B36J28.USD","LU1989771016.USD","LU1989772840.SGD","IE00B4R5TH58.HKD","LU0882574055.USD","BK4581","LU2362541273.HKD","LU0823417653.USD"],"gpt_icon":0},{"id":"2572531510","title":"Press Release: Elutia Announces Closing of BioEnvelope Business Sale to Boston Scientific Corporation for $88 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2572531510","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572531510?lang=en_us&edition=fundamental","pubTime":"2025-10-01 20:41","pubTimestamp":1759322460,"startTime":"0","endTime":"0","summary":"- Strengthened balance sheet to fully fund development and launch of NXT-41 platform -. - Biologics for breast reconstruction represents $1.5 billion U.S. total addressable market -. GAITHERSBURG, Md., Oct. 01, 2025  -- Elutia Inc.  , a pioneer in drug-eluting biomatrix technologies, today announced the closing of the sale of its BioEnvelope business, including the EluPro and CanGaroo bioenvelopes, to Boston Scientific Corporation  for $88 million in cash.With this closing, Elutia will leverage its proven drug-eluting biologics platform with a more concentrated focus on advancing NXT-41x, a biomatrix that directly addresses the root causes of reconstruction infections following mastectomy. NXT-41x combines excellent handling, optimal biologics, and powerful, extended antibiotic release to provide protection while supporting tissue regeneration.Each year, more than 150,000 breast reconstruction procedures are performed in the U.S., and approximately one in three patients suffer serious ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1983299246.USD","LU1989764748.USD","R","LU2491050154.USD","LU1791710400.SGD","03160","LU0114720955.EUR","LU0238689110.USD","LU0048584097.USD","LU2324357040.USD","LU2357305700.SGD","LU2506952170.USD","BK4139","LU0823417737.USD","LU0251132253.USD","LU0077335932.USD","LU0122379950.USD","LU1366192091.USD","LU1057294990.SGD","LU0528227936.USD","BK4581","LU1548497426.USD","LU1989764664.SGD","SG9999013999.USD","LU0011850046.USD","LU1791710582.SGD","LU2491050071.SGD","BK4022","LU0267386448.USD","IE00BJJMRZ35.SGD","LU0266013472.USD","TM","LU1291159041.SGD","LU1720051108.HKD","LU1989772923.USD","IE00BJT1NW94.SGD","BSX","LU2491049909.HKD","LU0823417653.USD","LU2362541513.USD","IE0002141913.USD","LU0225283273.USD","IE00B4R5TH58.HKD","LU2087625088.SGD","SG9999001176.SGD","LU2265009873.SGD","IE0009355771.USD","BK4504","LU1061106388.HKD","ELUT"],"gpt_icon":0},{"id":"2567024331","title":"Elutia Announces Newly Published Clinical Data Demonstrating that Biologic Envelopes Support CIED Stabilization and Ease of Reoperation","url":"https://stock-news.laohu8.com/highlight/detail?id=2567024331","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567024331?lang=en_us&edition=fundamental","pubTime":"2025-09-16 20:00","pubTimestamp":1758024000,"startTime":"0","endTime":"0","summary":"- Findings highlight the potential of antibiotic-eluting bioenvelopes to transform cardiac implantable electronic device (CIED) pocket management - GAITHERSBURG, Md., Sept.  16, 2025  (GLOBE NEWSWIRE)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/09/16/3150708/0/en/Elutia-Announces-Newly-Published-Clinical-Data-Demonstrating-that-Biologic-Envelopes-Support-CIED-Stabilization-and-Ease-of-Reoperation.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ELUT"],"gpt_icon":0},{"id":"2566700983","title":"Elutia Is Maintained at Buy by Lake Street","url":"https://stock-news.laohu8.com/highlight/detail?id=2566700983","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566700983?lang=en_us&edition=fundamental","pubTime":"2025-09-11 00:18","pubTimestamp":1757521080,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ELUT/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  September 10, 2025 12:18 ET (16:18 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ELUT"],"gpt_icon":0},{"id":"2566375607","title":"Elutia Inc. Unveils Presentation Detailing Innovative Drug-Eluting Biomatrices and Market Strategy","url":"https://stock-news.laohu8.com/highlight/detail?id=2566375607","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566375607?lang=en_us&edition=fundamental","pubTime":"2025-09-10 22:16","pubTimestamp":1757513787,"startTime":"0","endTime":"0","summary":"Elutia Inc. recently presented at the H.C. Wainwright 27th Annual Global Investment Conference, where CEO C. Randal Mills and CFO Matt Ferguson outlined the company's strategic advancements in drug-eluting biomatrices. Elutia is positioned as a leader in this field, focusing on developing products that combine biomatrices with pharmaceuticals to offer significant patient benefits. Key highlights from the presentation include the company's first FDA-cleared drug-eluting bioenvelope for use with cardiac implantable electronic devices  and its commercial adoption in 180 centers supported by seven group purchasing organizations . The presentation also noted the company's monetization success, with an 8x revenue realization from Boston Scientific, and its first-mover advantage in the $1.5 billion breast reconstruction market. Elutia is debt-free, with its platform de-risked and available cash supporting its operations through clearance and commercialization. You can access the full presenta","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250910:nNDL57K9Mp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1983299246.USD","LU1989764748.USD","LU2491050154.USD","LU0432979614.USD","LU1791710400.SGD","LU0353189680.USD","LU0238689110.USD","SGXZ57979304.SGD","LU2324357040.USD","LU2242649171.HKD","LU0251132253.USD","LU0077335932.USD","LU0122379950.USD","LU1366192091.USD","LU1057294990.SGD","LU0528227936.USD","LU2362541273.HKD","LU1548497426.USD","LU0345769631.USD","SG9999013999.USD","LU0823416689.USD","LU2506951875.HKD","LU0011850046.USD","LU1791710582.SGD","LU2491050071.SGD","LU0267386448.USD","IE00BJJMRZ35.SGD","LU0187121727.USD","LU0266013472.USD","LU1291159041.SGD","LU1989771016.USD","LU2506952097.USD","IE00BJT1NW94.SGD","BSX","LU0950375773.USD","LU2491049909.HKD","LU0823417653.USD","LU2362541513.USD","IE0002141913.USD","LU2506951958.HKD","LU1023059063.AUD","LU1720051017.SGD","LU1804176565.USD","LU2112291526.USD","LU2265009873.SGD","IE0009355771.USD","BK4504","BK4585","LU1061106388.HKD","ELUT"],"gpt_icon":0},{"id":"2566909686","title":"Boston Scientific to Buy Elutia's Bioenvelope Business for $88M","url":"https://stock-news.laohu8.com/highlight/detail?id=2566909686","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566909686?lang=en_us&edition=fundamental","pubTime":"2025-09-09 20:58","pubTimestamp":1757422680,"startTime":"0","endTime":"0","summary":"Boston Scientific has agreed to buy Elutia's bioenvelopes, which protect patients receiving implantable medical devices, for $88 million in cash.Elutia said the deal will allow it to eliminate debt, resolve litigation and fund its development of breast-reconstruction technology without diluting shares.The deal is expected to close in the fourth quarter.Elutia shares were trading 1.6% higher at $1.91.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BJJMRZ35.SGD","LU2324357040.USD","LU1791710582.SGD","LU2265009873.SGD","LU2491049909.HKD","SG9999001176.USD","LU1153585028.USD","LU0345769128.USD","LU0432979614.USD","LU0950375773.USD","IE00BFTCPJ56.SGD","LU2362541513.USD","IE00BJT1NW94.SGD","LU0048584097.USD","LU1989772840.SGD","LU1366192091.USD","IE00B4R5TH58.HKD","SG9999001176.SGD","BK4581","LU1989764748.USD","LU1061106388.HKD","LU0266013472.USD","LU1720051108.HKD","LU2242649171.HKD","IE0009355771.USD","LU0114720955.EUR","LU2357305700.SGD","BK4139","BK4504","BK4585","LU0011850046.USD","BSX","SG9999013999.USD","ELUT","LU0882574055.USD","LU0122379950.USD","LU2087625088.SGD","LU2491050071.SGD","LU1989772923.USD","LU2112291526.USD","LU2506951958.HKD","LU2362540622.SGD","LU0823417737.USD","LU0823416689.USD","LU2506951875.HKD","LU0267386448.USD","LU1791710400.SGD","LU2506952097.USD","LU1983299246.USD","LU0345769631.USD"],"gpt_icon":0},{"id":"2566973156","title":"BRIEF-Elutia Announces Sale of BioEnvelope Business to Boston Scientific Corporation for $88 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2566973156","media":"Reuters","labels":["corporation","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566973156?lang=en_us&edition=fundamental","pubTime":"2025-09-09 20:33","pubTimestamp":1757421228,"startTime":"0","endTime":"0","summary":"BRIEF-Elutia Announces Sale of BioEnvelope Business to Boston Scientific Corporation for $88 MillionSept 9 (Reuters) - Boston Scientific Corp BSX.N:ELUTIA ANNOUNCES SALE OF BIOENVELOPE BUSINESS TO BOS","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250909:nTUABHR3MH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0114720955.EUR","LU1989772840.SGD","LU0823416689.USD","LU2357305700.SGD","LU0353189680.USD","IE0009355771.USD","LU2265009873.SGD","LU1804176565.USD","LU0225283273.USD","LU1057294990.SGD","LU1061106388.HKD","LU2242649171.HKD","SGXZ57979304.SGD","LU0882574055.USD","LU2324357040.USD","IE00B2B36J28.USD","ELUT","LU0432979614.USD","LU1720051108.HKD","LU0267386448.USD","IE00BJT1NW94.SGD","LU1718418525.SGD","SG9999001176.SGD","LU0048584097.USD","LU0238689110.USD","LU2506952097.USD","LU0077335932.USD","IE00B4R5TH58.HKD","LU2362540622.SGD","LU2491049909.HKD","LU2491050071.SGD","LU0345769631.USD","LU2506951875.HKD","LU0353189763.USD","LU0122379950.USD","LU1791710400.SGD","LU1989772923.USD","LU1720051017.SGD","LU1989764664.SGD","LU1366192091.USD","SG9999013999.USD","LU1983299246.USD","IE00BJJMRZ35.SGD","LU1989764748.USD","IE0002141913.USD","BSX","LU2244417387.USD","LU0345769128.USD","LU2506951958.HKD","LU1153585028.USD"],"gpt_icon":0},{"id":"2564717693","title":"Elutia Selected to Exhibit EluPro™ Antibiotic Eluting BioEnvelope at Vizient Innovative Technology Exchange","url":"https://stock-news.laohu8.com/highlight/detail?id=2564717693","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564717693?lang=en_us&edition=fundamental","pubTime":"2025-09-04 20:00","pubTimestamp":1756987200,"startTime":"0","endTime":"0","summary":"GAITHERSBURG, Md., Sept.  04, 2025  (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”), a pioneer in drug-eluting biomatrix technologies, today announced that it has been selec","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/09/04/3144438/0/en/Elutia-Selected-to-Exhibit-EluPro-Antibiotic-Eluting-BioEnvelope-at-Vizient-Innovative-Technology-Exchange.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ELUT"],"gpt_icon":0},{"id":"2562466197","title":"Elutia to Participate in Upcoming Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2562466197","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562466197?lang=en_us&edition=fundamental","pubTime":"2025-08-27 20:00","pubTimestamp":1756296000,"startTime":"0","endTime":"0","summary":"GAITHERSBURG, Md., Aug.  27, 2025  (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia”), a pioneer in drug-eluting biomatrix technologies, today announced that Dr. Randy Mills, President and Chie","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/08/27/3139946/0/en/Elutia-to-Participate-in-Upcoming-Investor-Conferences.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ELUT","BK4139"],"gpt_icon":0},{"id":"2561140481","title":"BRIEF-Elutia Enters Fifth Amendment To Credit Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2561140481","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561140481?lang=en_us&edition=fundamental","pubTime":"2025-08-21 04:34","pubTimestamp":1755722095,"startTime":"0","endTime":"0","summary":"BRIEF-Elutia Enters Fifth Amendment To Credit Agreement Aug 20  - Elutia Inc ELUT.O:ELUTIA INC - ON AUGUST 15 ENTERS FIFTH AMENDMENT TO CREDIT AGREEMENT - SEC FILINGELUTIA INC - SWK FACILITY PROVIDES $25 MILLION TERM LOAN - SEC FILINGSource text: [ID:n0001104659-25-080916]Further company coverage: ELUT.O ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250820:nFWN3UC0SQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ELUT"],"gpt_icon":0},{"id":"2561890034","title":"Elutia Inc - on August 15 Enters Fifth Amendment to Credit Agreement - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2561890034","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561890034?lang=en_us&edition=fundamental","pubTime":"2025-08-21 04:17","pubTimestamp":1755721040,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250820:nFWN3UC0SQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ELUT","BK4139"],"gpt_icon":0},{"id":"2561489008","title":"Elutia Inc - SWK Facility Provides $25 Mln Term Loan - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2561489008","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561489008?lang=en_us&edition=fundamental","pubTime":"2025-08-21 04:17","pubTimestamp":1755721040,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250820:nFWN3UC0SQ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ELUT","BK4139"],"gpt_icon":0},{"id":"2561887481","title":"Elutia Inc. Amends Credit Agreement, Capitalizes $60,000 in Fees into $25 Million Term Loan","url":"https://stock-news.laohu8.com/highlight/detail?id=2561887481","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561887481?lang=en_us&edition=fundamental","pubTime":"2025-08-21 04:16","pubTimestamp":1755720994,"startTime":"0","endTime":"0","summary":"Elutia Inc., a Delaware-based corporation, has entered into a Fifth Amendment to its existing Credit Agreement, originally dated August 10, 2022, with SWK Funding LLC and associated lenders. This amendment involves the capitalization of certain amounts into the unpaid principal balance of a $25 million senior secured term loan. Specifically, all accrued and unpaid interest as of August 2025, a $50,000 amendment fee agreed upon in June 2025, and an additional $10,000 amendment fee will be included in the principal balance. The amendment signifies Elutia's continued financial arrangements with its lenders, enhancing its capital structure.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Elutia Inc. published the original content used to ge","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250820:nNDL8wnynC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4164","ELUT","SWKH","BK4139"],"gpt_icon":0},{"id":"2560183090","title":"Cantor Fitzgerald Adjusts Elutia Price Target to $5 From $7, Maintains Overweight Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2560183090","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560183090?lang=en_us&edition=fundamental","pubTime":"2025-08-18 21:59","pubTimestamp":1755525543,"startTime":"0","endTime":"0","summary":"Elutia Inc (ELUT) has an average rating of Buy and mean price target of $7.50, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks and","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ELUT"],"gpt_icon":0},{"id":"2559943649","title":"Elutia Inc reports results for the quarter ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2559943649","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559943649?lang=en_us&edition=fundamental","pubTime":"2025-08-16 02:14","pubTimestamp":1755281686,"startTime":"0","endTime":"0","summary":"Elutia Inc reports results for the quarter ended June 30 - Earnings SummaryElutia Inc ELUT.OQ reported a quarterly adjusted loss of 23 cents per share for the quarter ended June 30, higher than the sa","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250815:nL8N3U712V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ELUT"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":32,"code":"91000000","status":"200"}]}}